I am a Technical Analyst working on COVID-19 vaccine impact, with a particular focus on translating modelling insights for policy and stakeholders.
Prior to this role, I worked with the Vaccine Impact Modelling Consortium. Our work focused on aggregating and assessing estimates of the burden of vaccine preventable diseases and the impact of vaccination across low- and middle-income countries.
I also continue to collaborate on work on neglected tropical diseases as I previously worked with the Neglected Tropical Disease Modelling Consortium where my main focus was on cross-cutting disease areas and schistosomiasis (which remains an endemic parasitic disease affecting millions of people). My work provided policy relevant insights on treatment strategies for schistosomiasis.
et al., 2021, How can the public health impact of vaccination be estimated?, Bmc Public Health, Vol:21
et al., 2021, Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis., Plos Negl Trop Dis, Vol:15
et al., 2021, Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?, Bmj Global Health, Vol:6, ISSN:2059-7908
et al., 2021, How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases, Gates Open Research, Vol:5, Pages:112-112
et al., 2021, Dynamics of SARS-CoV-2 with waning immunity in the UK population, Philosophical Transactions of the Royal Society B-biological Sciences, Vol:376, ISSN:0962-8436